Mark D. Long - Concepedia

Author

Mark D. Long

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

, G., D Long, Mark, Long, Mark, M. D. Long, Mackenzie Long, Mark D Long, Mark D. Long, Mark Long, Muyang Long

431

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Dana-Farber Cancer Institute Cancer Genetics (United States)Harvard University The Ohio State University

About

Mark D. Long is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, tumor biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	514
2	Cell Biology	5	5	114
3	Immunology	5	5	151
4	Engineering	4	4	358
5	Health Sciences	1	1	24

Mark D. Long

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas Spencer R. Rosario, Mark D. Long, Hayley C. Affronti, Nature Communications EngineeringPathologyPan-cancer AnalysisTranscriptional Metabolic DysregulationMetabolic Flux	2018	275
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer Yota Yasumizu, Hasan Rajabi, Caining Jin, Nature Communications	2020	191
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s Takaaki Oba, Mark D. Long, Tibor Keler, Nature Communications	2020	126
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model Johannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink, Gastroenterology	2021	106
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation Yixuan Zhou, Ingmar N. Bastian, Mark D. Long, Proceedings of the National Academy of Sciences	2021	96
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer Song Liu, Junko Matsuzaki, Lei Wei, Journal for ImmunoTherapy of Cancer	2019	86
MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells Masayuki Hagiwara, Yota Yasumizu, Nami Yamashita, Cancer Research	2020	78
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer Nami Yamashita, Mark D. Long, Atsushi Fushimi, Journal for ImmunoTherapy of Cancer	2021	73
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells Tsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, Cancer Research	2019	69
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells Masayuki Hagiwara, Atsushi Fushimi, Nami Yamashita, Oncogene	2021	68

Page 1